January 18, 2017 5:21 PM ET


Company Overview of Integrity Pharmaceutical Corp.

Company Overview

As of February 9, 2004, Integrity Pharmaceutical Corp. was acquired by Xanodyne Pharmacal, Inc. Integrity Pharmaceutical Corp. is a manufacturer of OB/GYN and Urology healthcare products and nutritional supplements. Among its products are Urimax, Colo-fresh, Sureprin, Pycnogenol, and Stuartnatal. The Stuartnatal brand line of prenatal vitamins was acquired from Wyeth-Ayerst Laboratories in April 2000.

9084 Technology Dr

Fishers, IN 46038-3079

United States

Founded in 1998





Key Executives for Integrity Pharmaceutical Corp.

Integrity Pharmaceutical Corp. does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
21st Century Animal Health United States
3 Buds' Organics LLC United States
4P Therapeutics LLC United States
60° Pharmaceuticals, LLC United States
7 Oaks Pharmaceutical Corp. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Integrity Pharmaceutical Corp., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.